What is he best known for?
The fields of study he is best known for:
His main research concerns Nanotechnology, Microfluidics, Cell biology, Biomedical engineering and Laminar flow.
His Substrate study, which is part of a larger body of work in Nanotechnology, is frequently linked to Drop, bridging the gap between disciplines.
His Microfluidics research is multidisciplinary, incorporating elements of Microscale chemistry, Analytical chemistry, Biophysics, Microchannel and Membrane.
He has included themes like Spheroid, Regulation of gene expression, Endocytosis and Cell adhesion in his Cell biology study.
His Biomedical engineering study combines topics from a wide range of disciplines, such as Endothelial stem cell and Myocyte, Myogenesis, Skeletal muscle.
The study incorporates disciplines such as Streamlines, streaklines, and pathlines, Hydrodynamic focusing and Transfection in addition to Laminar flow.
His most cited work include:
- Soft Lithography in Biology and Biochemistry (2160 citations)
- Patterning proteins and cells using soft lithography (1358 citations)
- Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. (619 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Nanotechnology, Microfluidics, Cell biology, Biophysics and Biomedical engineering.
Shuichi Takayama specializes in Nanotechnology, namely Monolayer.
His Microfluidics research incorporates elements of Fluidics, Optoelectronics, Microchannel, Biological system and Microscale chemistry.
The concepts of his Cell biology study are interwoven with issues in Embryonic stem cell, In vitro and Cellular differentiation.
His study in Aqueous two-phase system is interdisciplinary in nature, drawing from both Dextran, Polyethylene glycol and Polymer.
He most often published in these fields:
- Nanotechnology (41.23%)
- Microfluidics (39.18%)
- Cell biology (18.68%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (18.68%)
- Organoid (4.10%)
- Microfluidics (39.18%)
In recent papers he was focusing on the following fields of study:
Shuichi Takayama spends much of his time researching Cell biology, Organoid, Microfluidics, Biophysics and Microscale chemistry.
His research integrates issues of Epithelium, DNA and 3D cell culture in his study of Cell biology.
The Microfluidics study combines topics in areas such as Fluidics, Capacitive coupling, Microscopy, Optoelectronics and Biological system.
Shuichi Takayama combines subjects such as Stress, Signalling pathways, Spheroid, Spheroid formation and Aqueous solution with his study of Biophysics.
His studies deal with areas such as Process and In vitro model as well as Spheroid.
His research in Coacervate intersects with topics in Nanotechnology and Phase.
Between 2017 and 2021, his most popular works were:
- Nonadhesive Alginate Hydrogels Support Growth of Pluripotent Stem Cell-Derived Intestinal Organoids. (58 citations)
- Perspective: The promise of multi-cellular engineered living systems. (58 citations)
- Dispersible hydrogel force sensors reveal patterns of solid mechanical stress in multicellular spheroid cultures (37 citations)
In his most recent research, the most cited papers focused on:
Shuichi Takayama focuses on Cell biology, Organoid, Biophysics, Cell and Aqueous solution.
His Cell biology study incorporates themes from Stromal cell, 3D cell culture, Carcinogenesis, Human gut and Cellular model.
His research on Organoid often connects related areas such as Stem cell.
His Biophysics research includes elements of Spheroid, Stress and Signalling pathways.
Shuichi Takayama interconnects Computational biology, Organ-on-a-chip and In vivo in the investigation of issues within Cell.
The various areas that Shuichi Takayama examines in his Aqueous solution study include Coacervate, Reagent, Dextran and Dissolution.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
